Ozempic is a story about forecasts, assumptions and speculation. Nothing much has happened yet. But it’s still a big story because the forecasts are so extraordinary. I am reminded of the early days of Covid-19 when every analyst was trying to forecast how the virus would impact companies’ business models. It was very difficult to think through Covid-19’s implications. But people knew it was going to be big (It took an imaginative analyst in March 2020 to make the connection between the virus, the lockdowns, and the boom in online poker). Why is Ozempic (from a family of drugs called…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .